FilingSEC EDGAR6-K
Alterity Therapeutics Announces CEO Participation in Investor Conference
· SEC accepted
StageUpcoming
Filing content
Alterity Therapeutics announced that its CEO will participate in a fireside chat at the Craig-Hallum Virtual Biotech Catalyst Conference on October 22, 2026.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…